![](/img/cover-not-exists.png)
4515 POSTER Zoledronic acid is cost saving and improves quality-adjusted survival in the prevention of skeletal related events in patients with bone metastases secondary to advanced renal cell carcinoma: a German perspective
Botteman, M., Foley, I., Marfatia, A., Chen, Y.M.Volume:
5
Language:
english
Journal:
European Journal of Cancer Supplements
DOI:
10.1016/S1359-6349(07)71146-1
Date:
September, 2007
File:
PDF, 61 KB
english, 2007